Should a statin be routinely prescribed for primary prevention of cardiovascular disease in diabetes mellitus?
- Statins research unfinished saga: desirability versus feasibility. Fisman, Enrique Z.; Adler, Yehuda; Tenenbaum, Alexander // Cardiovascular Diabetology;2005, Vol. 4, p8
Drugs in the same class are generally thought to be therapeutically equivalent because of similar mechanisms of action (the so-called "class effect"). However, statins differ in multiple characteristics, including liver and renal metabolism, half-life, effects on several serum lipid components,...
- GPs urged to use statins in every patient with diabetes. Wilkinson, Emma // Pulse;1/12/2004, Vol. 64 Issue 2, p7
Reports on British medical authorities' claim that every diabetic patient should be treated with a statin. Reason behind the recommendation; Effect of statin treatment on cardiovascular risk among diabetics.
- DIABETES DILEMMA. Krawczyk, Konrad W. // Cortlandt Forum;10/25/2003, Vol. 16 Issue 10, p44
Presents a question and answer advisory on the suitability of using lifelong statin and angiotensin converting enzyme inhibitor use by a diabetic. Consideration of the occurrence of hypertension; Reduction of risk of stroke; Citation of studies supporting the therapeutic efficacy of statin.
- Adherence to Statin Therapy and LDL Cholesterol Goal Attainment by Patients With Diabetes and Dyslipidemia. Parris, Elizabeth S.; Lawrence, David B.; Mohn, Lisa A.; Long, Laura B. // Diabetes Care;Mar2005, Vol. 28 Issue 3, p595
OBJECTIVE -- The purpose of this study was to assess the relationship between adherence to statin therapy and LDL cholesterol goal achievement in patients with diabetes and dyslipidemia. RESEARCH DESIGN AND METHODS -- The records of patients being medically treated for dyslipidemia in a managed...
- For Your Heart: Add Statins. Harrar, Sarí; Stuart, Annie // Prevention;Nov2003, Vol. 55 Issue 11, p176
Discusses research on the use of cholesterol-lowering statins as therapy for diabetics. Impact of using statin on the risk of cardiovascular disease.
- Statins under-prescribed in high-risk diabetics. Kelly, Brian // Pulse;10/4/2004, Vol. 64 Issue 39, p20
Reports on the underprescription of statins in high-risk diabetes patients in Great Britain. Improvement of secondary prevention.
- Have a statin, but not cake too. Sattar, Naveed // Diabetes Digest;2012, Vol. 11 Issue 2, p84
The article discusses several clinical trials focusing on dose-dependent statin treatment leading to an increased risk of diabetes in cardiovascular disease (CVD) patients. Patients under statin therapy have a greater risk of diabetes according to study on an analysis of the Women's Health...
- Resolution of Asymptomatic Myocardial Ischemia in Patients With Type 2 Diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) Study. Wackers, Frans J. Th.; Chyun, Deborah A.; Young, Lawrence H.; Heller, Gary V.; Iskandrian, Ami E.; Davey, Janice A.; Barrett, Eugene J.; Taillefer, Raymond; Wittlin, Steven D.; Filipchuk, Neil; Ratner, Robert E.; Inzucchi, Silvio E. // Diabetes Care;Nov2007, Vol. 30 Issue 11, p2892
OBJECTIVE -- The purpose of this study was to assess whether the prevalence of inducible myocardial ischemia increases over time in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS -- Participants enrolled in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study underwent...
- Statins and risk of developing diabetes. Kuritzky, Louis // Clinical Oncology Alert;May2010 Supplement, p9
The article discusses a research study on the association between statin treatment and increased risk of new onset-diabetes, published in a 2010 issue of the journal "The Lancet."